Hemogenyx Pharmaceuticals Plc
HEMO.L
Price:
$1.4597
Market Cap:
$18.06M
Hemogenyx Pharmaceuticals Plc, a preclinical-stage biotechnology company, focuses on the discovery, development, and commercialization of therapies and treatments for blood diseases. It is involved in developing products for bone marrow/hematopoietic stem cell (BM/HSC) transplant market, including CDX bi-specific antibody targeting relapsed/refractory acute myeloid leukaemia (R/R AML), subset of acute lymphoblastic leukaemia, and myelodysplastic syndrome conditioning bone marrow transplants to substitute traditional chemotherapy and/or radiation; HEMO-CAR-T therapy, a chimeric antigen receptor T-cells to identify and destroy human AML-derived cells in vitro and in vivo; and Human Postnatal H...[Read more]
Industry
Biotechnology
IPO Date
2015-11-09
Stock Exchange
LSE
Ticker
HEMO.L
The Enterprise Value as of September 2024 (TTM) for Hemogenyx Pharmaceuticals Plc (HEMO.L) is 19.76M
According to Hemogenyx Pharmaceuticals Plc’s latest financial reports and current stock price. The company's current Enterprise Value is 19.76M. This represents a change of -16.37% compared to the average of 23.62M of the last 4 quarters.
Hemogenyx Pharmaceuticals Plc (HEMO.L) Historical Enterprise Value (quarterly & annually)
How has HEMO.L Enterprise Value performed in the past?
The mean historical Enterprise Value of Hemogenyx Pharmaceuticals Plc over the last ten years is 11.31M. The current 19.76M Enterprise Value has changed 17.37% with respect to the historical average. Over the past ten years (40 quarters), HEMO.L's Enterprise Value was at its highest in in the December 2020 quarter at 41.66M. The Enterprise Value was at its lowest in in the March 2021 quarter at -9020793.07.
Average
11.31M
Median
7.33M
Minimum
668.65K
Maximum
39.85M
Hemogenyx Pharmaceuticals Plc (HEMO.L) Enterprise Value by Quarter and Year
Discovering the peaks and valleys of Hemogenyx Pharmaceuticals Plc Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 411.35%
Maximum Annual Enterprise Value = 39.85M
Minimum Annual Increase = -80.72%
Minimum Annual Enterprise Value = 668.65K
| Year | Enterprise Value | Change |
|---|---|---|
| 2023 | 27.67M | 99.46% |
| 2022 | 13.87M | 80.60% |
| 2021 | 7.68M | -80.72% |
| 2020 | 39.85M | 411.35% |
| 2019 | 7.79M | 11.75% |
| 2018 | 6.97M | 50.60% |
| 2017 | 4.63M | 172.46% |
| 2016 | 1.70M | 154.15% |
| 2015 | 668.65K | -70.48% |
Hemogenyx Pharmaceuticals Plc (HEMO.L) Average Enterprise Value
How has HEMO.L Enterprise Value performed in the past?
The current Enterprise Value of Hemogenyx Pharmaceuticals Plc (HEMO.L) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
16.41M
5-year avg
19.37M
10-year avg
11.31M
Hemogenyx Pharmaceuticals Plc (HEMO.L) Enterprise Value vs. Peers
How is HEMO.L’s Enterprise Value compared to its peers?
Hemogenyx Pharmaceuticals Plc’s Enterprise Value is greater than Omega Diagnostics Group PLC (-97152.00), greater than genedrive plc (10.25M), less than Avacta Group Plc (237.64M), less than Novacyt S.A. (20.20M), greater than Synairgen plc (-2209281.00),
| Company | Enterprise Value | Market cap |
|---|---|---|
| -97152.00 | $4.94M | |
| 10.25M | $11.35M | |
| 237.64M | $231.14M | |
| 20.20M | $50.57M | |
| -2209281.00 | $8.31M |
Build a custom stock screener for Hemogenyx Pharmaceuticals Plc (HEMO.L) and other stocks
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Hemogenyx Pharmaceuticals Plc using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
Hemogenyx Pharmaceuticals Plc (HEMO.L) and other stocks custom spreadsheet templates
The easiest way to analyze a company like Hemogenyx Pharmaceuticals Plc or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
Frequently asked questions❓
What is the Enterprise Value?
How can you use the Enterprise Value?
What is Hemogenyx Pharmaceuticals Plc's Enterprise Value?
What is the highest Enterprise Value for Hemogenyx Pharmaceuticals Plc (HEMO.L)?
What is the 3-year average Enterprise Value for Hemogenyx Pharmaceuticals Plc (HEMO.L)?
What is the 5-year average Enterprise Value for Hemogenyx Pharmaceuticals Plc (HEMO.L)?
How does the current Enterprise Value for Hemogenyx Pharmaceuticals Plc (HEMO.L) compare to its historical average?